Ascites promotes cell migration through the repression of miR-125b in ovarian cancer

Lan Yang; Xiaoli Zhang; Yiming Ma; Xinhua Zhao; Bin Li; Hongying Wang

doi:10.18632/oncotarget.16846

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Ascites promotes cell migration through the repression of miR-125b in ovarian cancer

Lan Yang, Xiaoli Zhang, Yiming Ma, Xinhua Zhao, Bin Li and Hongying Wang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:51008-51015. https://doi.org/10.18632/oncotarget.16846

Metrics: PDF 1535 views | HTML 2927 views | ?

Abstract

Lan Yang1,*, Xiaoli Zhang1,*, Yiming Ma1, Xinhua Zhao1, Bin Li2 and Hongying Wang1

1State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China

2Department of Gynecological Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China

*Co-first authors

Correspondence to:

Hongying Wang, email: [email protected]

Bin Li, email: [email protected]

Keywords: ovarian cancer, ascites, cell migration, TGF-β, miR-125b

Received: January 05, 2017 Accepted: March 14, 2017 Published: April 05, 2017

ABSTRACT

Interactions between ovarian cancer cells and the surrounding tumor microenvironment are not well characterized. Here, we investigated the molecular mechanisms by which malignant ascites promote the metastasis of ovarian cancer. It was found that ovarian cancer ascites promoted ovarian cancer cell migration which was attenuated by either heat inactivation or antibody blockade of TGF-β. High level (at ng/ml level) of TGF-β was detected in the ascites. In addition, ascites repressed the expression of miRNA-125b in a TGF-β-dependent manner. Mimic of miR-125b blocked ascites-induced cell migration. Furthermore, Gab2 (a target gene of miR-125b) was elevated by ascites in a TGF-β-dependent manner. And forced expression of Gab2 reversed the inhibition of migration induced by miR-125b mimic. Most importantly, the expression of miR-125b and Gab2 mRNA was negatively correlated in ovarian cancer specimens. Taken together, our finding suggested that TGF-β in ascites promoted cancer cell migration through repression of miR-125b in ovarian cancer. This might provide a novel therapeutic target for ovarian cancer in the future.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16846

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Ascites promotes cell migration through the repression of miR-125b in ovarian cancer

Abstract